US Stock MarketDetailed Quotes
TMO Thermo Fisher Scientific
- 603.790
- +6.870+1.15%
Close Oct 14 16:00 ET
- 603.790
- 0.0000.00%
Post 20:01 ET
230.65BMarket Cap37.46P/E (TTM)
604.540High595.233Low1.01MVolume600.790Open596.920Pre Close605.94MTurnover0.26%Turnover Ratio39.08P/E (Static)382.00MShares627.47852wk High4.86P/B230.12BFloat Cap414.49052wk Low1.48Dividend TTM381.13MShs Float667.714Historical High0.25%Div YieldTTM1.56%Amplitude11.885Historical Low602.076Avg Price1Lot Size
Thermo Fisher Scientific Stock Forum
Sign in to post a comment
Imagine getting paycheck on regular basis - that's the joy of dividend investing. The very first book I read on dividend investing is "The Complete Dividend Investing Guide That Works!" by KC Chong. KC Chong is the very same author of another best selling book of "The Complete Value Investing Guide That Works!".
While I am building a growth/ETF portfolio mainly focused on US stock market, I have also started a dividend portfolio with the goal of receiving passive regular inco...
While I am building a growth/ETF portfolio mainly focused on US stock market, I have also started a dividend portfolio with the goal of receiving passive regular inco...
loading...
37
6
Recent data shows that defensive sectors like utilities, consumer defensive, and healthcare have outperformed the information technology sector over the past month, reaching 52-week highs.
Notably, several stocks within these sectors have shown exceptional performance. Pharmaceutical giants with market values in the hundreds of billions, such as $Eli Lilly and Co (LLY.US)$, $Thermo Fisher Scientific (TMO.US)$, $AbbVie (ABBV.US)$, and ...
Notably, several stocks within these sectors have shown exceptional performance. Pharmaceutical giants with market values in the hundreds of billions, such as $Eli Lilly and Co (LLY.US)$, $Thermo Fisher Scientific (TMO.US)$, $AbbVie (ABBV.US)$, and ...
272
111
Columns Must Follow Portfolios Ⅱ
1. Chris Hohn completed exited $Thermo Fisher Scientific (TMO.US)$ . He increased his stake in Google $Alphabet-A (GOOGL.US)$ by nearly 400%.
2. Chuck Akre entered into $Airbnb (ABNB.US)$ in Q2. He trimmed a handful of positions and completely exited out of $Uber Technologies (UBER.US)$ .
3. David Abrams entered a huge position into $LOAR. Makes up 40% of his equity portfolio.
4. Edgar Wachenheim continues to love home builders, but not banks. He reduced his positions in $Goldman Sachs (GS.US)$ and ...
2. Chuck Akre entered into $Airbnb (ABNB.US)$ in Q2. He trimmed a handful of positions and completely exited out of $Uber Technologies (UBER.US)$ .
3. David Abrams entered a huge position into $LOAR. Makes up 40% of his equity portfolio.
4. Edgar Wachenheim continues to love home builders, but not banks. He reduced his positions in $Goldman Sachs (GS.US)$ and ...
+2
1
Disclaimer: this is not a suggestion to buy or sell. Trade at your own risk. You take full responsibility on your own action.
long:
qcom, ctra, hst
short:
tmo, pnw
#priceactiotrade
long:
qcom, ctra, hst
short:
tmo, pnw
#priceactiotrade
+2
5
Morning Movers
Gapping up
$Tesla (TSLA.US)$ stock soared 12% following the announcement of earlier releases for "more affordable" car versions, despite first-quarter results falling short of Wall Street estimates.
$AT&T (T.US)$ stock increased by 3.6% after reporting stronger-than-expected subscriber growth and surpassing free cash flow growth in the first quarter.
$Visa (V.US)$ stock grew 2.4% as the credit card company's second...
Gapping up
$Tesla (TSLA.US)$ stock soared 12% following the announcement of earlier releases for "more affordable" car versions, despite first-quarter results falling short of Wall Street estimates.
$AT&T (T.US)$ stock increased by 3.6% after reporting stronger-than-expected subscriber growth and surpassing free cash flow growth in the first quarter.
$Visa (V.US)$ stock grew 2.4% as the credit card company's second...
24
1
... 
Nvidia $NVIDIA (NVDA.US)$
Walmart $Walmart (WMT.US)$
$Advanced Micro Devices (AMD.US)$
Costco $Costco (COST.US)$
Taiwan Semiconductor $Taiwan Semiconductor (TSM.US)$
CrowdStrike $CrowdStrike (CRWD.US)$
JPMorgan $JPMorgan (JPM.US)$
Airbnb $Airbnb (ABNB.US)$
Palantir $Palantir (PLTR.US)$
Qualcomm $Qualcomm (QCOM.US)$
Target $Target (TGT.US)$
Bank of America $Bank of America (BAC.US)$
Wells Fargo $Wells Fargo & Co (WFC.US)$
Spotify $Spotify Technology (SPOT.US)$
...
Walmart $Walmart (WMT.US)$
$Advanced Micro Devices (AMD.US)$
Costco $Costco (COST.US)$
Taiwan Semiconductor $Taiwan Semiconductor (TSM.US)$
CrowdStrike $CrowdStrike (CRWD.US)$
JPMorgan $JPMorgan (JPM.US)$
Airbnb $Airbnb (ABNB.US)$
Palantir $Palantir (PLTR.US)$
Qualcomm $Qualcomm (QCOM.US)$
Target $Target (TGT.US)$
Bank of America $Bank of America (BAC.US)$
Wells Fargo $Wells Fargo & Co (WFC.US)$
Spotify $Spotify Technology (SPOT.US)$
...
13
3
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
The share price has tracked EPS growth, suggesting unchanged sentiment towards the shares. The recent sell-off could be an opportunity, given the long-term gain of 18% per year over half a decade. However, investors should note 1 warning sign for Thermo Fisher Scientific before investing.
Morning Movers
Gapping up
$Starbucks (SBUX.US)$ stock rose 3.7% after the coffee chain cut its annual sales forecast, warning of softer demand in January and a slow recovery in China. However, even more weakness had been expected following disappointing store traffic in November and December.
$Novo-Nordisk A/S (NVO.US)$ stock rose 0.5% after the Danish drugmaker forecast another year of double-digit growth due to the populari...
Gapping up
$Starbucks (SBUX.US)$ stock rose 3.7% after the coffee chain cut its annual sales forecast, warning of softer demand in January and a slow recovery in China. However, even more weakness had been expected following disappointing store traffic in November and December.
$Novo-Nordisk A/S (NVO.US)$ stock rose 0.5% after the Danish drugmaker forecast another year of double-digit growth due to the populari...
17
Investors anticipate robust growth from Thermo Fisher Scientific, justifying its high P/E ratio. Shareholders' confidence in future earnings supports the stock's price, which is likely to persist unless conditions alter.
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
CY90 : Major is Reit. wow
YOHO3318 OP CY90 : yeah, as REITs are required to distribute at least 90% of their income
Mr Pistachio : DBS is a divd ATM long term hold but your cost basis in the teens is best
YOHO3318 OP Mr Pistachio : waiting for it to pull back to collect more =)
Chilli Doggie : The anticipation for the rate cut had been dragged too long contributing to the uptrend. Could pullback or push even higher once announcement is made.
I’m just waiting for the hype to end before adding more REIT positions.
View more comments...